M Vergnes Selected Research

M Vergnes Research Topics

5	Absence Epilepsy (Childhood Absence Epilepsy) 11/2001 - 02/2000
3	Seizures (Absence Seizure) 01/2002 - 02/2000
1	Sleep Wake Disorders 01/2002
1	Hypersensitivity (Allergy) 11/2001
1	Epilepsy (Aura) 07/2000
1	Tonic-Clonic Epilepsy (Epilepsy, Tonic Clonic) 02/2000

2	gamma-Aminobutyric Acid (GABA)IBA 11/2001 - 02/2000
2	GABA-A Receptors (GABA(A) Receptor)IBA 11/2001 - 02/2000
1	prolactin-releasing peptide receptorIBA 01/2002
1	Prolactin-Releasing Hormone (Prolactin Releasing Hormone)IBA 01/2002
1	Glial Fibrillary Acidic ProteinIBA 10/2000
1	Glutamate-Ammonia Ligase (Glutamine Synthetase)IBA 10/2000
1	Glutamate DehydrogenaseIBA 10/2000
1	Arginine (L-Arginine)FDA Link 07/2000
1	Ethosuximide (Zarontin)FDA LinkGeneric 07/2000
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2000
1	Anticonvulsants (Antiepileptic Drugs)IBA 07/2000
1	Valproic Acid (Depakote)FDA LinkGeneric 07/2000
1	Nitric Oxide Synthase (NO Synthase)IBA 07/2000
1	Messenger RNA (mRNA)IBA 03/2000
1	ApoferritinsIBA 03/2000
1	GABA-B Receptor AntagonistsIBA 02/2000
1	FG 7142IBA 02/2000
1	CGP 56999AIBA 02/2000
1	BenzodiazepinesIBA 02/2000
1	BicucullineIBA 02/2000
1	ConvulsantsIBA 02/2000
1	Pharmaceutical PreparationsIBA 02/2000
1	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 02/2000
1	Kainic Acid (Kainate)IBA 02/2000
1	PicrotoxinIBA 02/2000
1	StrychnineIBA 02/2000
1	3-Mercaptopropionic Acid (3 Mercaptopropionic Acid)IBA 02/2000
1	methyl 6,7- dimethoxy- 4- ethyl- beta- carboline- 3- carboxylateIBA 02/2000

1	Therapeutics 01/2002